 | Karyopharm Therapeutics (NASDAQ:KPTI) Shares Down 2.4%
americanbankingnews.com - May 14 at 1:11 PM |
 | Tuesday 5/11 Insider Buying Report: KPTI, TUP
nasdaq.com - May 11 at 5:59 PM |
| Insider Buying: Karyopharm Therapeutics Inc. (NASDAQ:KPTI) EVP Purchases 23,250 Shares of Stock
americanbankingnews.com - May 11 at 12:12 PM |
| Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Up 4% Following Insider Buying Activity
americanbankingnews.com - May 11 at 10:19 AM |
| Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Director Garen G. Bohlin Acquires 4,000 Shares of Stock
americanbankingnews.com - May 10 at 8:58 PM |
| Karyopharm Therapeutics (NASDAQ:KPTI) Price Target Cut to $15.00
americanbankingnews.com - May 10 at 11:02 AM |
| SVB Leerink Cuts Karyopharm Therapeutics (NASDAQ:KPTI) Price Target to $15.00
americanbankingnews.com - May 10 at 11:02 AM |
 | Some Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Analysts Just Made A Major Cut To Next Year's Estimates
finance.yahoo.com - May 9 at 12:54 PM |
| Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Just Reported And Analysts Have Been Cutting Their Estimates
nasdaq.com - May 7 at 1:16 PM |
| Q2 2021 EPS Estimates for Karyopharm Therapeutics Inc. Boosted by Analyst (NASDAQ:KPTI)
americanbankingnews.com - May 7 at 10:42 AM |
|
| Karyopharm Therapeutics Inc. (NASDAQ:KPTI) to Post Q2 2021 Earnings of ($0.65) Per Share, Jefferies Financial Group Forecasts
americanbankingnews.com - May 6 at 7:44 AM |
| SVB Leerink Weighs in on Karyopharm Therapeutics Inc.'s Q2 2021 Earnings (NASDAQ:KPTI)
americanbankingnews.com - May 6 at 7:44 AM |
| Q2 2021 Earnings Forecast for Karyopharm Therapeutics Inc. Issued By Wedbush (NASDAQ:KPTI)
americanbankingnews.com - May 6 at 7:44 AM |
| Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Receives Consensus Recommendation of "Buy" from Brokerages
americanbankingnews.com - May 5 at 6:48 AM |
 | Karyopharm Therapeutics Inc. (KPTI) CEO Richard Paulson on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 8:35 PM |
| Karyopharm Therapeutics (NASDAQ:KPTI) PT Lowered to $19.00
americanbankingnews.com - May 4 at 1:04 PM |
| Karyopharm Therapeutics (NASDAQ:KPTI) Price Target Cut to $30.00
americanbankingnews.com - May 4 at 1:04 PM |
| Karyopharm Therapeutics (NASDAQ:KPTI) Issues Quarterly Earnings Results
americanbankingnews.com - May 4 at 8:22 AM |
| Karyopharm Therapeutics Inc (KPTI) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 3 at 6:23 PM |
| Karyopharm Therapeutics (NASDAQ:KPTI) PT Lowered to $15.00 at SVB Leerink
americanbankingnews.com - May 3 at 2:34 PM |
| Karyopharm Therapeutics (NASDAQ:KPTI) Sets New 52-Week Low on Analyst Downgrade
americanbankingnews.com - May 3 at 1:44 PM |
| Karyopharm Therapeutics (KPTI) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 3 at 1:22 PM |
| Karyopharm Announces the Appointment of Richard Paulson as President and Chief Executive Officer
finance.yahoo.com - May 3 at 8:21 AM |
| Karyopharm Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress
finance.yahoo.com - May 3 at 8:21 AM |
| $26.50 Million in Sales Expected for Karyopharm Therapeutics Inc. (NASDAQ:KPTI) This Quarter
americanbankingnews.com - May 2 at 1:02 AM |
| Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Expected to Announce Earnings of -$0.70 Per Share
americanbankingnews.com - April 30 at 8:16 PM |
 | Earnings Preview: Karyopharm Therapeutics
benzinga.com - April 30 at 4:22 PM |
| Jefferies Financial Group Weighs in on Karyopharm Therapeutics Inc.'s Q1 2021 Earnings (NASDAQ:KPTI)
americanbankingnews.com - April 30 at 6:26 AM |
| Karyopharm Therapeutics (KPTI) Set to Announce Quarterly Earnings on Monday
americanbankingnews.com - April 29 at 8:16 AM |
 | BRIEF-Karyopharm Announces European Medicines Agency's Validation Of Its Type Ii Variation Marketing Authorization Application For Nexpovio® (Selinexor) In Combination With ...
msn.com - April 26 at 3:14 PM |
|
| If You Had Bought Karyopharm Therapeutics' (NASDAQ:KPTI) Shares A Year Ago You Would Be Down 61%
nasdaq.com - April 24 at 11:24 AM |
| Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Down 3.2%
americanbankingnews.com - April 23 at 1:36 PM |
| Karyopharm Therapeutics (NASDAQ:KPTI) Hits New 52-Week Low at $9.34
americanbankingnews.com - April 19 at 12:48 PM |
| Karyopharm Announces Publication of Health-Related Quality of Life Outcomes from Phase 3 SEAL Study of Selinexor in Advanced Unresectable Dedifferentiated Liposarcoma in Future Oncology
finance.yahoo.com - April 19 at 8:32 AM |
| Market Sentiment Around Loss-Making Karyopharm Therapeutics Inc. (NASDAQ:KPTI)
finance.yahoo.com - April 14 at 9:18 AM |
| Karyopharm Stock Is Trading Higher After China's NMPA Signs Off Early-Stage ATG-019 Study In Cancer Settings
finance.yahoo.com - April 6 at 1:16 PM |
 | Antengene Announces NMPA Approval of IND Application for ATG-019 in Patients with Advanced Solid Tumors or Non-Hodgkin's Lymphoma
markets.businessinsider.com - April 6 at 8:15 AM |
| Karyopharm Therapeutics Stock Appears To Be Possible Value Trap
finance.yahoo.com - April 5 at 5:48 PM |
| Karyopharm's Selinexor Receives Conditional Approval In Europe For Type Of Blood Cancer
markets.businessinsider.com - March 29 at 2:45 PM |
| Karyopharm Receives Conditional Marketing Authorization from the European Commission for NEXPOVIO® (selinexor) in Combination with Dexamethasone for the Treatment of Adult Patients with Relapsed and or Refractory Multiple Myeloma
finance.yahoo.com - March 29 at 2:44 PM |
| Expanded Partnership with Medidata Supports Karyopharm’s Mission to Develop First-in-Class Therapeutics
finance.yahoo.com - March 10 at 1:46 PM |
| Antengene Announces NDA for ATG-010 (Selinexor) Granted Priority Review by China's NMPA
markets.businessinsider.com - February 23 at 7:41 PM |
| Karyopharm Announces Upcoming Virtual Investor Conference Participation
finance.yahoo.com - February 17 at 7:45 PM |
| Analysts Have Lowered Expectations For Karyopharm Therapeutics Inc. (NASDAQ:KPTI) After Its Latest Results
finance.yahoo.com - February 13 at 1:08 PM |
| Karyopharm Therapeutics EPS in-line, beats on revenue
seekingalpha.com - February 12 at 8:06 PM |
| News Flash: 9 Analysts Think Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Earnings Are Under Threat
nasdaq.com - February 12 at 3:06 PM |
| Karyopharm Therapeutics (KPTI) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - February 11 at 1:01 PM |
| Recap: Karyopharm Therapeutics Q4 Earnings
finance.yahoo.com - February 11 at 1:01 PM |
| JNJ Single-shot COVID-19 Vaccine At FDA Altar, KPTI Expands Xpovio's Footprint, OTLK On Track
markets.businessinsider.com - February 5 at 3:04 AM |
| Karyopharm Announces XPOVIO® (selinexor) Receives Regulatory Approval in Israel for the Treatment of Patients with Multiple Myeloma and Diffuse Large B-Cell Lymphoma
finance.yahoo.com - February 4 at 12:00 PM |
